The biotechnology chemicals industry is at the intersection of biology and chemistry, where firms utilize biological systems to produce chemicals. Companies in this sector develop bioprocesses for a range of products, including pharmaceuticals, agricultural products, and industrial chemicals. The industry is evolving rapidly, driven by advancements in genomics and biomanufacturing technology. With a growing demand for sustainable solutions, firms are increasingly focused on bio-based alternatives to traditional chemical processes. The integration of computational methods into research and production promises improvements in efficiency and product development, showcasing the industry's potential to address both market demands and environmental concerns.

This listing highlights 21 biotechnology chemicals companies operating in various locations, including the USA, India, and Europe. Ranging from startups to established firms, these companies employ between 11 and 10,000 individuals, showcasing the variety in scale. Founded from the 1930s to the 2020s, their specializations include antibody development, microbial fermentation, and biopharmaceutical manufacturing. Many are integrating cutting-edge technologies to create innovative solutions tailored for healthcare, agriculture, and industrial applications, positioning them for future growth in a competitive marketplace.

Read on to discover the top biotechnology chemicals companies.

Top 21 Biotechnology Chemicals Companies

1. Zymergen, Inc.

• Website: zymergen.com
• Ownership type: Corporate
• Headquarters: Emeryville, California, United States (USA)
• Latest funding: $300.0M, July 2022
• Founded year: 2013
• Headcount: 501-1000
• LinkedIn: zymergen-inc-

Zymergen, Inc., founded in 2013 and based in Emeryville, California, is a biotechnology firm that specializes in leveraging genomics and machine learning to develop chemical-producing genetically modified organisms. The company aims to provide innovative solutions for chemical production, targeting sectors such as defense and large-scale manufacturing. Zymergen's approach combines advanced biological engineering with data-driven methodologies to optimize the production of chemicals, making them a notable player in the biotechnology chemicals industry. In July 2022, Zymergen secured $300 million in funding, reflecting strong investor confidence in their technology and business model.

2. BioLegend

• Website: biolegend.com
• Ownership type: Corporate
• Headquarters: San Diego, California, United States (USA)
• Employee distribution: United States (USA) 92%, Taiwan 3%, Other 5%
• Latest funding: $5.2B, July 2021
• Founded year: 2002
• Headcount: 501-1000
• LinkedIn: biolegend

BioLegend, founded in 2002 and based in San Diego, California, is a biotechnology company that specializes in the development and manufacturing of antibodies and reagents tailored for biomedical research. The company provides essential tools that cater to various applications, including immunology, oncology, neuroscience, and proteogenomics. BioLegend serves a wide range of researchers in both academic and industrial settings, emphasizing their commitment to delivering high-quality products and custom solutions. With a workforce of approximately 677 employees, the company operates globally, ensuring that they meet the needs of their customers effectively. In July 2021, BioLegend secured significant funding amounting to $5.25 billion, which highlights their strong market position and potential for future growth.

3. Cadila Pharmaceuticals Limited

• Website: cadilapharma.com
• Ownership type: Corporate
• Headquarters: Ahmedabad, Gujarat, India
• Employee distribution: India 97%, Other 3%
• Latest funding: September 2021
• Founded year: 1951
• Headcount: 5001-10000
• LinkedIn: cadila-pharmaceuticals

Cadila Pharmaceuticals Limited, established in 1951, is a prominent pharmaceutical company based in Ahmedabad, Gujarat, India. With a workforce of over 8,300 employees, the company specializes in manufacturing a wide array of products, including active pharmaceutical intermediates, finished formulations, and biotechnology products. Cadila is dedicated to providing affordable and innovative medical solutions, aiming to enhance health outcomes for patients worldwide. The company has a robust research and development division, with a team of 350 scientists focused on addressing unmet medical needs through cutting-edge research. Cadila's commitment to quality is reflected in its state-of-the-art manufacturing facilities, which comply with international standards. The company has a global presence, operating in regulated markets such as the USA, Europe, and Japan, and has established strategic collaborations in over 100 countries. Cadila's mission is to discover, develop, and market pharmaceutical products that prevent, diagnose, alleviate, and cure diseases, demonstrating its integral role in the biotechnology sector.

4. BOC Sciences

• Website: bocsci.com
• Ownership type: Private
• Headquarters: Shirley, New York, United States (USA)
• Employee distribution: United States (USA) 67%, Iraq 33%
• Founded year: 2005
• Headcount: 501-1000
• LinkedIn: boc-sciences

BOC Sciences, founded in 2005 and based in Shirley, New York, is a private chemical manufacturer that specializes in high-quality chemical production and research and development services. The company caters primarily to pharmaceutical and biotechnology firms, offering a broad array of products that support drug discovery and life sciences. Their product offerings include small-molecule inhibitors, pharmaceutical excipients, and various life science reagents, which are essential for innovative research and development. BOC Sciences also provides custom synthesis and analytical services, demonstrating their commitment to meeting the specific needs of their clients. With a workforce of around 501-1000 employees, the company has established a significant presence in the industry, focusing on delivering competitive solutions to enhance research efforts.

5. Biosynth Carbosynth

• Website: carbosynth.com
• Ownership type: Private
• Headquarters: Thal, St. Gallen, Switzerland
• Founded year: 1965
• Headcount: 201-500
• LinkedIn: biosynth-carbosynth

Biosynth Carbosynth, based in Thal, St. Gallen, Switzerland, is a biotechnology company that has been operational since 1965. The firm specializes in the manufacture and supply of high-quality chemicals, peptides, and biologics tailored for the life sciences sector. They cater primarily to the pharmaceutical and diagnostic industries, providing essential raw materials and custom synthesis services that ensure reliable supply chains for research and development. With a workforce of approximately 138 employees, the company operates multiple facilities across three continents, allowing them to meet the needs of a global clientele. Their extensive product offerings include carbohydrates, nucleosides, enzyme substrates, and a wide range of biologics, which are critical for various applications in diagnostics, vaccines, and pharmaceuticals. Biosynth Carbosynth prides itself on its ability to deliver complex chemical solutions and custom synthesis projects, making it a trusted partner for scientists and researchers worldwide.

6. PROBIOMED S.A. de C.V.

• Website: probiomed.com.mx
• Ownership type: Corporate
• Headquarters: Mexico
• Employee distribution: Mexico 99%
• Latest funding: May 2022
• Founded year: 1970
• Headcount: 501-1000
• LinkedIn: probiomedmx

PROBIOMED S.A. de C.V. is a Mexican biopharmaceutical company established in 1970. The company specializes in the research, development, manufacturing, and commercialization of pharmaceutical products designed to enhance human health. With a workforce of approximately 657 employees, PROBIOMED is dedicated to providing high-tech biopharmaceutical solutions for various serious diseases, including cancer, chronic kidney failure, rheumatoid arthritis, multiple sclerosis, and diabetes. Their product portfolio features a wide array of chemical synthesis generics and biocomparables, such as cytokines, monoclonal antibodies, fusion proteins, and recombinant vaccines. These products are aimed at treating autoimmune diseases, chronic degenerative disorders, hematological and metabolic disorders, as well as malignant neoplasms. PROBIOMED's commitment to improving health outcomes is evident in their efforts to ensure that patients around the globe have access to the treatments they need.

7. AgBiome

• Website: agbiome.com
• Ownership type: Venture Capital
• Headquarters: Durham, North Carolina, United States (USA)
• Employee distribution: United States (USA) 100%
• Latest funding: Series D, $116.0M, September 2021
• Founded year: 2012
• Headcount: 51-200
• LinkedIn: agbiome

AgBiome is an agricultural biotechnology company based in Durham, North Carolina, founded in 2012. The company specializes in developing microbial products aimed at crop protection, offering innovative solutions such as fungicides to help farmers manage crop diseases sustainably. AgBiome's research and development efforts focus on creating effective alternatives to traditional synthetic chemicals, catering primarily to agricultural producers. Their proprietary GENESIS platform enables the isolation and screening of microbes from various environments, leading to the development of novel products that enhance food production and promote human and animal health. AgBiome has secured significant funding, including $116 million in Series D financing as of September 2021, which supports their ongoing research and product development initiatives. Additionally, AgBiome has achieved B Corporation certification, reflecting their commitment to social and environmental performance.

8. Marinova Pty Ltd

• Website: marinova.com.au
• Ownership type: Private
• Headquarters: Cambridge, Tasmania, Australia
• Employee distribution: Australia 100%
• Founded year: 2003
• Headcount: 11-50
• LinkedIn: marinova-pty-ltd

Marinova Pty Ltd, founded in 2003 and based in Cambridge, Tasmania, is a biotechnology company dedicated to the research, development, and production of high purity fucoidan compounds sourced from select species of brown seaweed. The company has carved out a niche in the biotechnology chemicals sector by providing bioactive extracts that cater to health applications, particularly in the pharmaceutical and nutritional industries. Marinova is recognized for its innovative extraction technology, which allows for the production of fucoidan extracts without harsh chemicals or solvents, ensuring high purity and bioactivity. Their products are utilized in various health applications, including immune health, cancer research, and skincare. Marinova collaborates with leading research institutions and maintains a robust research program, contributing to the scientific understanding of fucoidan and its potential benefits. Their Maritech® brand of organic fucoidan extracts has gained global regulatory acceptance, further solidifying their position in the market.

9. FUJIFILM Diosynth Biotechnologies

• Website: fujifilmdiosynth.com
• Ownership type: Corporate
• Headquarters: Morrisville, North Carolina, United States (USA)
• Employee distribution: Denmark 43%, United States (USA) 40%, United Kingdom (UK) 17%
• Latest funding: $890.0M, August 2019
• Founded year: 2011
• Headcount: 1001-5000
• LinkedIn: fujifilm-diosynth-biotechnologies

FUJIFILM Diosynth Biotechnologies, founded in 2011, is a biotechnology company based in Morrisville, North Carolina. The firm specializes in contract development and manufacturing services tailored for biologics, vaccines, and advanced therapies. They collaborate with pharmaceutical and biotechnology companies, providing expertise in cGMP processes to ensure the safe and effective delivery of products. With facilities in the United States, Denmark, the United Kingdom, and Japan, FUJIFILM Diosynth Biotechnologies supports clients through all stages of drug development, from initial research to commercialization. Their capabilities include mammalian cell culture, microbial fermentation, and advanced therapies such as gene and cell therapy. The company has made significant investments to expand its manufacturing capacity, reflecting its commitment to meeting the evolving needs of the biotechnology sector.

10. Invitris

• Website: invitris.com
• Ownership type: Venture Capital
• Headquarters: Munich, Bavaria, Germany
• Employee distribution: Germany 89%, United Kingdom (UK) 11%
• Latest funding: Other (Grant), February 2025
• Founded year: 2022
• Headcount: 1-10
• LinkedIn: invitris

Invitris, founded in 2022 and based in Munich, Germany, is a biotechnology company dedicated to the development and manufacturing of synthetic proteins. The firm specializes in creating innovative therapeutic solutions aimed at combating antimicrobial resistance, a growing global health concern, and enhancing agricultural productivity. Their technology leverages cell-free expression systems to produce proteins with high yields and purity, allowing for the creation of entirely novel proteins with unique mechanisms of action. Invitris serves a range of customers, including healthcare providers and agricultural firms, seeking advanced protein-based solutions. The company has also been recognized for its potential, having originated from the successful iGEM Munich Team and securing non-dilutive funding to support its mission. With a focus on human health, veterinary applications, and industrial chemistry, Invitris is positioned to make a significant impact in the biotechnology sector.

11. FIMECS, Inc.

• Website: fimecs.com
• Ownership type: Corporate
• Headquarters: Fujisawa, Kanagawa, Japan
• Employee distribution: Japan 100%
• Latest funding: $29.9M, February 2024
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: fimecs

FIMECS, Inc., founded in 2018 and based in Fujisawa, Kanagawa, Japan, is a biotechnology firm dedicated to advancing drug discovery and development. The company specializes in creating innovative medicines aimed at 'undruggable' proteins, particularly in the field of oncology. FIMECS leverages its proprietary technology, RaPPIDS™, to facilitate the development of targeted protein degradation agents. This platform allows for rapid identification and optimization of compounds that can effectively target challenging proteins. FIMECS actively collaborates with pharmaceutical companies and research institutions, enhancing its research capabilities and expanding its reach in the market. In February 2024, the company secured approximately $29.9 million in funding, underscoring its potential for growth and innovation in the biotechnology sector.

12. etherna

• Website: etherna.be
• Ownership type: Venture Capital
• Headquarters: Niel, Flanders, Belgium
• Employee distribution: Belgium 100%
• Latest funding: Series B, $38.9M, August 2022
• Founded year: 2013
• Headcount: 51-200
• LinkedIn: etherna-engineering-rna

etherna is a biotechnology company based in Niel, Belgium, founded in 2013. The company specializes in RNA therapeutics and offers manufacturing services to pharmaceutical and biotech firms. With a focus on innovative RNA technology, etherna supports the development and production of nucleic acid-based therapeutics and vaccines. They have a strong portfolio of intellectual property, particularly in customizable Lipid Nano Particles (cLNPs), which are crucial for effective RNA delivery. etherna has recently secured significant funding, amounting to approximately €38.9 million in a Series B round in August 2022, which underscores their growth potential and commitment to advancing RNA medicine. Their team is equipped with extensive expertise in RNA chemistry and process technologies, allowing them to tackle complex challenges in the field efficiently.

13. PersisGen

• Website: persisgen.com
• Ownership type: Private
• Headquarters: Tehran, Tehran, Iran
• Employee distribution: Iran 100%
• Founded year: 2016
• Headcount: 51-200
• LinkedIn: persisgenpar

PersisGen Par, established in 2016 and based in Tehran, Iran, operates as a biotechnology accelerator. The company specializes in the production of recombinant drugs and human vaccines, playing a crucial role in the biotechnology ecosystem. PersisGen supports startups and pharmaceutical firms by providing essential infrastructure, technical expertise, and funding necessary for drug development and manufacturing. They have made notable strides in the industry, including being the second producer of Anakinra globally under the brand name Perkinra, and producing drugs for specific medical conditions such as neonatal respiratory distress syndrome. Their services also include contract research and manufacturing, showcasing their commitment to advancing biotechnology in Iran and beyond.

14. Hayashibara Co., Ltd.

• Website: hayashibara.co.jp
• Ownership type: Private
• Headquarters: Okayama, Okayama, Japan
• Employee distribution: Japan 100%
• Founded year: 1932
• Headcount: 501-1000
• LinkedIn: hayashibara-co-ltd-

Hayashibara Co., Ltd., now operating under the name Nagase Viita, was founded in 1932 and is based in Okayama, Japan. The company specializes in biotechnology, focusing on the development and supply of a wide range of materials. Their product offerings include food ingredients, pharmaceutical components, personal care products, and functional colorants. Nagase Viita is dedicated to providing high-quality, sustainable solutions that meet the needs of various industries. The company emphasizes research and innovation, leveraging natural resources such as enzymes and microorganisms to create effective and environmentally friendly products. They are committed to sustainability and actively work towards reducing environmental impact through their operations. With a workforce of approximately 797 employees, Nagase Viita continues to contribute to advancements in biotechnology and the chemical industry.

15. Adimab

• Website: adimab.com
• Ownership type: Venture Capital
• Headquarters: Lebanon, New Hampshire, United States (USA)
• Employee distribution: United States (USA) 96%, Lebanon 4%
• Latest funding: January 2020
• Founded year: 2007
• Headcount: 51-200
• LinkedIn: adimab-llc

Adimab, founded in 2007 and based in Lebanon, New Hampshire, is a biotechnology company that specializes in biologics discovery and engineering. The company has developed a proprietary yeast-based platform that enables the generation of therapeutic antibodies and multispecifics. Over its 15 years of operation, Adimab has collaborated with over 115 partners, including major pharmaceutical companies and biotech firms, to advance more than 500 therapeutic programs. Their focus on generating high-quality therapeutic leads has resulted in over 70 clinical programs originating from their platform. Adimab's expertise lies in antibody discovery, engineering of protein-based therapeutics, and the development of multispecifics, including T cell engagers. The company emphasizes a collaborative culture and is committed to making a meaningful impact on human health through its innovative approaches in drug development.

16. Vickro Biopharma Private Limited

• Website: vickrobiopharma.com
• Ownership type: Private
• Headquarters: Hyderabad, Telangana, India
• Employee distribution: India 100%
• Founded year: 2016
• Headcount: 501-1000
• LinkedIn: vickro-biopharma

Vickro Biopharma Private Limited, established in 2016 and based in Hyderabad, Telangana, India, is a biotechnology manufacturer that specializes in the production of probiotics, enzymes, and nutraceuticals. The company operates a modern manufacturing facility equipped for large-scale fermentation and purification processes. Vickro Biopharma serves multiple sectors, including healthcare, agriculture, and environmental management, providing innovative solutions aimed at enhancing health and sustainability. Their research and development efforts focus on creating stable probiotic solutions and enzymes, showcasing their commitment to quality and innovation. The company is certified with ISO 9001:2008, GMP, FSSC 22000, and FSSAI, reflecting their adherence to industry standards. Vickro Biopharma also offers contract manufacturing and private labeling services, further expanding their role in the biotechnology chemicals industry.

17. PlantForm Corporation

• Website: plantformcorp.com
• Ownership type: Venture Capital
• Headquarters: Toronto, Ontario, Canada
• Employee distribution: Canada 91%, Brazil 9%
• Latest funding: Other (Grant), $25,000, February 2018
• Founded year: 2008
• Headcount: 11-50
• LinkedIn: plantform-corporation

PlantForm Corporation, founded in 2008 and based in Toronto, Ontario, is a biopharmaceutical company dedicated to the rapid development and production of specialty antibody and protein drugs. Utilizing its proprietary _vivo_ XPRESS® technology platform, PlantForm focuses on creating biosimilars and medical countermeasures. The company’s pipeline includes notable products such as biosimilar versions of Keytruda® and Lucentis®, as well as innovative treatments for ricin exposure and other health threats. PlantForm has received funding, including a grant of $25,000 in 2018, which supports its research and development efforts. The company collaborates with various pharmaceutical firms and research institutions, enhancing its capabilities in producing biologics that are essential for treating critical illnesses.

18. Biosynth

• Website: biosynth.com
• Ownership type: Private Equity
• Headquarters: Thal, St. Gallen, Switzerland
• Employee distribution: United Kingdom (UK) 31%, United States (USA) 23%, Netherlands 22%, Other 24%
• Latest funding: November 2021
• Founded year: 1966
• Headcount: 501-1000
• LinkedIn: biosynth-carbosynth

Biosynth, founded in 1966 and headquartered in Thal, St. Gallen, Switzerland, operates as a private equity-owned chemical manufacturer and life sciences supplier. The company specializes in providing critical raw materials and custom synthesis services tailored for the pharmaceutical and diagnostics industries. Their product offerings include carbohydrates, nucleosides, biologics, and a variety of other chemicals essential for research and development. With a workforce of approximately 422 employees, Biosynth has established a global footprint, with facilities across Europe, the United States, and Asia. The company prides itself on its ability to deliver high-quality products and services, including complex chemical synthesis and GMP manufacturing, which are vital for the biotechnology sector. Biosynth's commitment to innovation and quality positions it as a significant player in the biotechnology chemicals market.

19. Phenotypeca

• Website: phenotypeca.com
• Ownership type: Private
• Headquarters: Nottingham, England, United Kingdom (UK)
• Employee distribution: United Kingdom (UK) 100%
• Founded year: 2018
• Headcount: 11-50
• LinkedIn: phenotypeca

Phenotypeca, founded in 2018 and based in Nottingham, UK, is a biotechnology firm dedicated to the development and manufacturing of recombinant protein therapeutics. The company leverages its proprietary QTL technology to create and customize premium recombinant proteins, which are essential for various therapeutic applications. Their offerings include biosimilars and recombinant albumin, aimed at enhancing product quality and optimizing production processes for pharmaceutical and biotechnology firms. Phenotypeca has established partnerships with notable organizations, including the Bill & Melinda Gates Foundation, to facilitate access to vaccines and therapeutics in underserved regions. With a team of experts in strain engineering and genomics, Phenotypeca is positioned to address complex challenges in protein manufacturing, making significant strides in the biotechnology sector.

20. BiCT srl - Biological and Chemical Technologies

• Website: bict.it
• Ownership type: Private
• Headquarters: Villanova Del Sillaro, Lombardy, Italy
• Employee distribution: Italy 75%, United States (USA) 25%
• Founded year: 2002
• Headcount: 11-50
• LinkedIn: bict-srl---biological-and-chemical-technologies

BiCT srl - Biological and Chemical Technologies, founded in 2002 and based in Villanova Del Sillaro, Lombardy, Italy, is a private biotechnology firm with a workforce of 24 employees. The company specializes in the research, development, and production of innovative solutions in the pharmaceutical, cosmetic, and nutraceutical sectors. BiCT is dedicated to enhancing health and well-being through advanced biotechnological processes. Their offerings include a range of products and services that cater to the needs of businesses looking to innovate and improve their product lines. The company operates with a strong emphasis on sustainability, aiming to create processes that are less impactful on the environment. BiCT's customer base includes various businesses that seek collaboration in R&D, highlighting their role as a partner in innovation. They have established a solid reputation in the industry, focusing on the development of bioactive ingredients and processes that contribute to health and wellness.

21. Neuron Bio

• Website: neuronbio.com
• Ownership type: Private
• Headquarters: Granada, Andalusia, Spain
• Employee distribution: Spain 100%
• Founded year: 2005
• Headcount: 11-50
• LinkedIn: neuron-bio

Neuron Bio, founded in 2005 and based in Granada, Spain, is a biotechnology company that specializes in creating biosolutions tailored for the pharmaceutical and agro-food sectors. The company operates through two main divisions: Neuron Biolabs, which focuses on biopharmaceutical applications, and Neol Bio, which is dedicated to industrial biotechnology. Neuron Bio has developed innovative processes in microbial biotechnology, producing products such as Omega-3 DHA oil derived from microalgae and diagnostic tools for Alzheimer's disease. Their clientele includes businesses seeking advanced biotechnological solutions, highlighting their role in enhancing product offerings in the pharmaceutical and food industries. Neuron Bio is also publicly traded on the Mercado Alternativo Bursátil (MAB) in Spain, indicating a level of market engagement and transparency in their operations.

Biotechnology Chemicals Insights: Key Companies

Want to Find More Biotechnology Chemicals Companies?

With Inven you'll also get to know the company's:

• Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
• Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
• Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!